Omnipod 5 International Rollout
Type 1 & Type 2 Diabetes
Key Facts
About Insulet
Insulet Corporation is a mission-driven leader in tubeless insulin pump technology, dedicated to simplifying diabetes management and improving quality of life. Its core achievement is the Omnipod 5 Automated Insulin Delivery System, the #1 prescribed insulin pump, which has demonstrated significant clinical benefits in both type 1 and type 2 diabetes. The company's strategy leverages a disruptive pharmacy benefit distribution model to build direct patient relationships and drive adoption, supported by innovative marketing and a pipeline focused on expanding indications and platform integration.
View full company profileTherapeutic Areas
Other Type 1 & Type 2 Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| GPX-002 | Genprex | Preclinical |
| Control-IQ+ Software Enhancements | Tandem Diabetes | Iterative Development |
| Tandem Mobi iOS App & Expansion | Tandem Diabetes | Development/Regulatory |
| Afrezza® | MannKind Corp | Approved |